Thursday, September 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

PrimeEnergy Shares Tumble as Crude Oil Collapse Erodes Profits

Felix Baarz by Felix Baarz
September 14, 2025
in Commodities, Earnings, Energy & Oil
0
PrimeEnergy Stock
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

PrimeEnergy Resources Corporation finds itself navigating turbulent market conditions as volatile oil prices create significant headwinds. The energy producer’s latest quarterly results reveal substantial financial pressure despite increased production in certain segments, painting a challenging picture for investors.

Second Quarter Financial Performance Reveals Significant Declines

The company’s Q2 2025 financial report demonstrates considerable deterioration across key metrics. Revenue plummeted 35% to $42 million, compared to $64.8 million during the same period last year. The profit decline proved even more dramatic, collapsing from $19.7 million to just $3.2 million. On a per-share basis, earnings fell from $7.77 to $1.33.

Crude Oil Price Weakness Drives Financial Setback

This substantial downturn stems primarily from deteriorating crude oil market conditions. Oil sales revenue dropped sharply from $56.2 million to $34.2 million, reflecting a dual challenge: production volumes declined 14% while realized selling prices simultaneously fell 30%.

The natural gas segment presented similarly concerning results, with revenues nearly halving to just $43,000 despite increased production volumes. The lone positive emerged in natural gas liquids, where sales grew 5% through higher volumes that offset lower pricing.

Strategic Capital Allocation Amid Market Challenges

Despite these market difficulties, PrimeEnergy maintains its established capital allocation strategy. During the second quarter, the company repurchased shares at an average price of $173.43. Since initiating the buyback program, management has allocated $113.5 million toward share repurchases.

Should investors sell immediately? Or is it worth buying PrimeEnergy?

Operationally, the company continues pursuing expansion initiatives:
* Planned capital expenditures of $98-129 million for 43-44 horizontal wells
* Continued focus on core operating regions in Texas and Oklahoma, particularly the Permian Basin
* Generated $56.9 million in free cash flow during the first half despite challenging conditions

Diverging Outlook for Oil and Gas Markets

Market forecasts present a mixed picture for energy commodities. The U.S. Energy Information Administration projects Brent crude will average $58 per barrel in Q4 2025 before declining to approximately $50 by early 2026, primarily due to market oversupply.

Natural gas markets tell a different story, with Henry Hub spot prices forecast to reach $4.30 per MMBtu in 2026. This anticipated strengthening reflects increasing LNG export demand and tightening supply-demand dynamics. For PrimeEnergy, currently expanding its gas and NGL production capabilities, this potential price recovery could provide meaningful upside.

The critical question remains whether PrimeEnergy can successfully navigate current market challenges until natural gas prices recover, or whether continued pressure on crude oil markets will create additional downward momentum for the company’s shares.

Ad

PrimeEnergy Stock: Buy or Sell?! New PrimeEnergy Analysis from September 18 delivers the answer:

The latest PrimeEnergy figures speak for themselves: Urgent action needed for PrimeEnergy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 18.

PrimeEnergy: Buy or sell? Read more here...

Tags: PrimeEnergy
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Synopsys Stock
Analysis

Chip Designer Synopsys Plunges on Dismal Earnings and Slashed Forecast

September 18, 2025
Danaher Stock
Analysis

Danaher Shares Show Signs of Potential Rebound After Prolonged Slump

September 18, 2025
Lynas Stock
Asian Markets

Lynas Stock Surges Amid Rare Earths Market Transformation

September 18, 2025
Next Post
Semler Scientific Stock

Investor Lawsuits Mount Against Semler Scientific Over Undisclosed DOJ Probe

Xencor Stock

Xencor's Clinical Milestones Set to Define Biotech Investment Case

MP Materials Stock

Diverging Investment Patterns Emerge in MP Materials Stock

Recommended

Financing and retirement

Navigating the Retirement Redefinition: Unveiling the Next Era of Financial Security

2 years ago
Tetra Tech Stock

Market Puzzled by Tetra Tech’s Share Decline Despite Strong Earnings

3 weeks ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Biopharmaceutical

Title Lexaria Bioscience Corp Launches Innovative Study on DehydraTECHProcessed GLP1 Drugs and Cannabidiol for Diabetes and Weight Loss

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase DIS Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Danaher Shares Show Signs of Potential Rebound After Prolonged Slump

Lynas Stock Surges Amid Rare Earths Market Transformation

Ocugen Forges Strategic Alliance with Korean Pharma Giant

Salesforce Targets Defense and Cybersecurity Sectors with AI Expansion

Regulatory Scrutiny Intensifies for Telehealth Provider Hims & Hers

Oracle’s AI Ambition: A High-Stakes Balancing Act

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Shares Signal Potential Turnaround After Steep Decline

by Andreas Sommer
September 18, 2025
0

A wave of cautious optimism is beginning to emerge for Danish pharmaceutical giant Novo Nordisk following a...

Wolfspeed Stock

Wolfspeed Shares Swing Wildly Following Key Product Launch

September 18, 2025
Synopsys Stock

Chip Designer Synopsys Plunges on Dismal Earnings and Slashed Forecast

September 18, 2025
Danaher Stock

Danaher Shares Show Signs of Potential Rebound After Prolonged Slump

September 18, 2025
Lynas Stock

Lynas Stock Surges Amid Rare Earths Market Transformation

September 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Shares Signal Potential Turnaround After Steep Decline
  • Wolfspeed Shares Swing Wildly Following Key Product Launch
  • Chip Designer Synopsys Plunges on Dismal Earnings and Slashed Forecast

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com